Previously, PPI was reported to decrease the phosphorylation of the NF-κB subunit p65 and its downstream target gene expression in the hepatocellular carcinoma cell line HepG2 (27) and human osteosarcoma cells (20), and reduce protein expression of p65 in human lung cancer cells (57). The gene discussed is NFKB1; the disease is lung cancer.